Abstract | BACKGROUND: Pharmacological interventions for prevention of sudden arrhythmic death in patients with chronic heart failure remain limited. Accumulating evidence suggests increased ventricular expression of T-type Ca(2+) channels contributes to the progression of heart failure. The ability of T-type Ca(2+) channel blockade to prevent lethal arrhythmias associated with heart failure has never been tested, however. METHODS AND RESULTS: We compared the effects of efonidipine and mibefradil, dual T- and L-type Ca(2+) channel blockers, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, on survival and arrhythmogenicity in a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor transgenic mice (dnNRSF-Tg), which is a useful mouse model of dilated cardiomyopathy leading to sudden death. Efonidipine, but not nitrendipine, substantially improved survival among dnNRSF-Tg mice. Arrhythmogenicity was dramatically reduced in dnNRSF-Tg mice treated with efonidipine or mibefradil. Efonidipine acted by reversing depolarization of the resting membrane potential otherwise seen in ventricular myocytes from dnNRSF-Tg mice and by correcting cardiac autonomic nervous system imbalance. Moreover, the R(-)-isomer of efonidipine, a recently identified, highly selective T-type Ca(2+) channel blocker, similarly improved survival among dnNRSF-Tg mice. Efonidipine also reduced the incidence of sudden death and arrhythmogenicity in mice with acute myocardial infarction. CONCLUSIONS: T-type Ca(2+) channel blockade reduced arrhythmias in a mouse model of dilated cardiomyopathy by repolarizing the resting membrane potential and improving cardiac autonomic nervous system imbalance. T-type Ca(2+) channel blockade also prevented sudden death in mice with myocardial infarction. Our findings suggest T-type Ca(2+) channel blockade is a potentially useful approach to preventing sudden death in patients with heart failure.
|
Authors | Hideyuki Kinoshita, Koichiro Kuwahara, Makoto Takano, Yuji Arai, Yoshihiro Kuwabara, Shinji Yasuno, Yasuaki Nakagawa, Michio Nakanishi, Masaki Harada, Masataka Fujiwara, Masao Murakami, Kenji Ueshima, Kazuwa Nakao |
Journal | Circulation
(Circulation)
Vol. 120
Issue 9
Pg. 743-52
(Sep 01 2009)
ISSN: 1524-4539 [Electronic] United States |
PMID | 19687356
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Calcium Channel Blockers
- Calcium Channels, L-Type
- Calcium Channels, T-Type
- Dihydropyridines
- Nitrophenols
- Organophosphorus Compounds
- Mibefradil
- efonidipine
- Nitrendipine
|
Topics |
- Animals
- Arrhythmias, Cardiac
(mortality, prevention & control)
- Autonomic Nervous System
(drug effects, physiology)
- Blood Pressure
- Body Weight
- Calcium Channel Blockers
(pharmacology)
- Calcium Channels, L-Type
(metabolism)
- Calcium Channels, T-Type
(metabolism)
- Cardiomyopathy, Dilated
(drug therapy, mortality)
- Death, Sudden, Cardiac
(prevention & control)
- Dihydropyridines
(pharmacology)
- Disease Models, Animal
- Female
- Mibefradil
(pharmacology)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Myocardial Infarction
(drug therapy, mortality)
- Myocytes, Cardiac
(physiology)
- Nitrendipine
(pharmacology)
- Nitrophenols
(pharmacology)
- Organophosphorus Compounds
(pharmacology)
- Patch-Clamp Techniques
|